中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 7
Jul.  2017
Turn off MathJax
Article Contents

A preliminary investigation and feature analysis of non-alcoholic fatty liver and nonalcoholic steatohepatitis in employees in an IT company

DOI: 10.3969/j.issn.1001-5256.2017.07.024
  • Received Date: 2017-01-03
  • Published Date: 2017-07-20
  • Objective To investigate the incidence rates and features of non-alcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) , and to provide a theoretical basis for health management and development of intervention and preventive measures in the health management department.Methods Physical examination reports in 2016 were obtained from a large IT company to analyze the incidence rates of NAFL and NASH in different age and sex groups, as well as the correlation with the indices including overweight (or obesity) , triglyceride, fasting blood glucose, blood uric acid, and blood pressure.The chi-square test was used for comparison of rates.Results In all employees, the incidence rates of NAFL and NASH were 4.51% and 17.64%, respectively, and the overall incidence rate of these two diseases was 22.15%.The NAFL-NASH group had significantly higher incidence rates of overweight (or obesity) (91.20% vs 12.68%, χ2=7571.9, P<0.001) , hyperlipidemia (95.06% vs 9.27%, χ2=9373.8, P<0.001) , and hyperuricemia (40.02% vs 10.51%, χ2=1591.90, P<0.001) than the non-NAFL-NASH group.Compared with female employees, male employees had significantly higher incidence rates of NAFL (6.78% vs 1.81%, χ2=190.35, P<0.001) and NASH (25.04% vs 5.06%, χ2=991.90, P<0.001) , as well as significantly higher incidence rates of overweight (or obesity) (40.90% vs 12.97%, χ2=1319.10, P<0.001) , hyperlipidemia (36.00% vs 16.07%, χ2=696.22, P<0.001) , hyperglycemia (2.17% vs 0.64%, χ2=53.82, P<0.01) , hyperuricemia (26.76%vs 1.69%, χ2=1581.10, P<0.001) , and hypertension (6.21% vs 1.22%, χ2=170.94, P<0.001) .Compared with those aged<35 years, the employees aged ≥35 years had significantly higher incidence rates of NAFL (8.13% vs 4.47%, χ2=41.56, P<0.001) and NASH (21.73% vs 16.76%, χ2=24.72, P<0.001) , as well as significantly higher incidence rates of hyperglycemia (2.79% vs1.43%, χ2=17.26, P<0.001) and hypertension (6.33% vs 4.03%, χ2=18.56, P<0.001) while="" there="" were="" no="" significant="" differences="" in="" the="" incidence="" rates="" of="" overweight="" or="" and="" high="" uric="" acid="" between="" these="" two="" groups="" all="" p="">0.05) .Conclusion Although IT employees are young, there is no significant reduction in the incidence rate of nonalcoholic fatty liver disease.The development of NAFL and NASH has the clinical features of overweight (or obesity) , hyperlipidemia, and hyperuricemia, which are commonly seen in male patients.Older employees have higher incidence rates of NAFL, NASH, hyperglycemia, and hypertension than younger employees.

     

  • loading
  • [1]The Chinese National Work-shop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association.Guidelines for management of nonalcoholic fatty liver disease:an updated and revised edition[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
    [2]FAN JG.Research advances in non-alcoholic fatty liver disease:a review of current status and prospect[J].J Clin Hepatol, 2015, 30 (7) :999-1001. (in Chinese) 范建高.非酒精性脂肪性肝病的研究现状与展望[J].临床肝胆病杂志, 2015, 30 (7) :999-1001.
    [3]PETTA S, GASTALDELLI A, REBELOS E, et al.Pathophysiology of non alcoholic fatty liver disease[J].Int J Mol Sci, 2016, 17 (12) :120-125.
    [4]CARR RM, ORANU A, KHUNGAR V.Nonalcoholic fatty liverdisease:pathophysiology and management[J].Gastroenterol Clin North Am, 2016, 45 (4) :639-652.
    [5]FAN JG, YAN SL.Metabolic syndrome and fatty liver[J].J Clin Hepatol, 2016, 32 (3) :407-410. (in Chinese) 范建高, 颜士林.代谢综合征与脂肪肝[J].临床肝胆病杂志, 2016, 32 (3) :407-410.
    [6]LIAO HL, XIAO XH.Research advance on mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease[J].J Clin Pathol Res, 2014, 34 (6) :831-836. (in Chinese) 廖海林, 肖新华.甘油三酯在非酒精性脂肪肝沉积的机制研究进展[J].临床与病理杂志, 2014, 34 (6) :831-836.
    [7]LISBOA QC, COSTA SM, COUTO CA.Current management of non-alcoholic fatty liver disease[J].Rev Assoc Med, 2016, 62 (9) :872-878.
    [8]WU F, HUANG J, CHEN XQ.Clinical analysis of nonalcoholic fatty liver disease[J].Chin J Pract Intern Med, 2016, 36 (Suppl 8) :38-39. (in Chinese) 吴奋, 黄静, 陈湘清.非酒精性脂肪肝临床特征分析[J].中国实用内科杂志, 2016, 36 (Suppl 8) :38-39.
    [9]XU BB, WANG BY.Nonalcoholic fatty liver disease and serum uric acid[J].J Clin Hepatol, 2016, 32 (3) :437-441. (in Chinese) 徐贝贝, 王炳元.非酒精性脂肪性肝病与血清尿酸[J].临床肝胆病杂志, 2016, 32 (3) :437-441.
    [10]ZHU JZ, HOLLIS-HANSEN K, WAN XY, et al.Clinical guidelines of non-alcoholic fatty liver disease:a systematic review[J].World JGastroenterol, 2016, 22 (36) :8226-8233.
    [11]ZENG Q.An introduction to functional medical[M].Beijing:People's Medical Publishing House, 2016:268-310. (in Chinese) 曾强.功能医学概论[M].北京:人民卫生出版社, 2016:268-310.
    [12]GAO X, JIN EH.Research progress of liver fatty deposits and type2 diabetes mellitus[J].Chin J Med Offic, 2015, 14 (5) :428-431. (in Chinese) 高翔, 靳二虎.肝脏脂肪沉积与2型糖尿病相关性研究进展[J].临床军医杂志, 2015, 14 (5) :428-431.
    [13]JIANG YY, LIU L.The research advances in the treatment of nonalcoholic fatty liver disease[J/CD].Chin J Liver Dis:Electronic E-dition, 2015, 7 (1) :127-128. (in Chinese) 江依勇, 刘丽.非酒精性脂肪肝治疗进展研究[J/CD].中国肝脏病杂志:电子版, 2015, 7 (1) :127-128.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2534) PDF downloads(411) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return